⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMUX News
Immunic, Inc. Common Stock
Form 8-K
sec.gov
IMUX
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
prnewswire.com
IMUX
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
prnewswire.com
GILD
INCY
BIIB
NVS
AMGN
JNJ
ABBV
BMY
AZN
MRK
PFE
TGTX
XNCR
CABA
IMUX
ZNTL
GLPG
CLNN
AUTL
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
prnewswire.com
IMUX
Immunic to Participate in Investor Conferences in March
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
prnewswire.com
IMUX
Immunic Announces Closing of Oversubscribed Private Placement Financing
prnewswire.com
IMUX